The Swemed Sense follicle aspiration needle causes less pain and bleeding than a conventional needle when used for oocyte aspiration, according to a multicentre study conducted in Sweden.
The study examined how much pain women experienced in an oocyte aspiration during IVF treatment using each needle.
It found that the Swemed Sense’s thinner tip reduces bleeding and pain without compromising oocyte retrieval time or the number of undamaged oocytes.
Results were presented at the annual meeting of ESHRE, the European Society of Human Reproduction and Embryology, in Rome.
The Swemed Sense was developed by Vitrolife.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData